An experimental drug may help curb blood sugar of patients with type2 diabetes without causing it to drop to extremely low levels. In a new study, a team of researchers has discovered that the compound–dubbed TTP399–improved the blood sugar control of patients, when it was added to metformin, the first-line medication for type 2 diabetes, …
Continue reading “Experimental Drug Promises a New Option for Type 2 Diabetes”